Status:
COMPLETED
Systolic Hypertension in the Elderly Program (SHEP)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Cardiovascular Diseases
Cerebrovascular Disorders
Eligibility:
All Genders
60-100 years
Phase:
PHASE3
Brief Summary
The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduced the combined incidence of fatal and non...
Detailed Description
BACKGROUND: More than 3 million persons in the United States over the age of 60 have isolated systolic hypertension. They face an excess risk (2-3 fold) of stroke, other cardiovascular disease and de...
Eligibility Criteria
Men and women, aged 60 or over, with isolated systolic hypertension.
Key Trial Info
Start Date :
June 1 1984
Trial Type :
INTERVENTIONAL
End Date :
October 1 1996
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000514
Start Date
June 1 1984
End Date
October 1 1996
Last Update
April 15 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.